A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge
- Conditions
- Hearing Loss, ConductiveBone Conduction Deafness
- Interventions
- Device: Bone Anchored Hearing AidDevice: Bonebridge
- Registration Number
- NCT01858246
- Lead Sponsor
- Ninewells Hospital
- Brief Summary
The Bonebridge is a new bone conducting implantable hearing aid. The investigators plan to randomize patients to receive either the Bonebridge or a conventional bone conducting hearing device. The investigators will then compare the surgical and audiological outcomes of the two groups.
- Detailed Description
The new Bonebridge fully implanted, except for an external sound processor. It does not have any percutaneous parts like the Bone Anchored Hearing Aid. The investigators believe that this may improve wound healing and reduce problems with wound infection and skin overgrowth seen in Bone Anchored Hearing Aids.
There may also be audiological improvements by the use of the Bonebridge as the physical separation of the vibrating part from the sound processor should reduce feedback. The company also claims other audiological improvements in the Bonebridge.
The investigators wish to demonstrate whether this is actually the case by performing a study directly comparing the outcomes of the two groups.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3
- Conductive Hearing Loss within criteria for Bonebridge
- Adults
- Children
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Bone Anchored Hearing Aid Bone Anchored Hearing Aid Implantation with a Bone Anchored Hearing Aid Bonebridge Bonebridge Implantation with a Bonebridge
- Primary Outcome Measures
Name Time Method Speech audiogram result at 6 months after switch on at 60 dBA in quiet using AB word lists Up to 1 year post-operatively We will record and compare the standard speech audiometry results at a specific sound level in order to make a direct comparison of devices
- Secondary Outcome Measures
Name Time Method Speech audiogram result at 60 dB A in noise using AB word lists Up to 1 year after implantation The speech audiogram will also be carried out in noise to demonstrate whether one device gives an appreciable advantage over another with respect to understanding in noise compared to silence.
Patient reported outcome data Up to 1 year following implantation Patients will be asked to complete the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale (HDSS) questionnaires
Time from surgery to device switch-on Up to 3 months The time (measured in days) will be recorded from the date of implantation to the date of its switch-on.
Number of patient episodes required during study period 1 year from implantation Time to complete wound healing Up to 3 months from implantation Measured in days, as judged subjectively by ENT medical and nursing staff
Trial Locations
- Locations (1)
Ninewells Hospital and Medical School
🇬🇧Dundee, United Kingdom